PHILADELPHIA– September 2, 2015 –– ERT, a leading global provider of high-quality patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions today announced the September 2015 installments to its Endpoints to Insights Educational Series. The series enables pharmaceutical researchers to participate in interactive programs in which ERT scientists and partner subject matter experts share their knowledge in optimizing the electronic collection of endpoint data and delivering real time business intelligence and analytics across clinical studies and programs.
Each month, the ERT Endpoints to Insights Webinar Series will focus on different aspects of effective endpoint data collection and on demand analytics for clinical trials and healthcare. The schedule of September webinars includes:
-September 15, 2015: Reporting vs. Analytics – Changing your Clinical Research Paradigm through Actionable Insights
-September 24, 2015: The Future of Cardiac Safety in Clinical Development (presented in Japanese)
-September 30, 2015: eCOA and Trial Design Considerations in Gastrointestinal Therapeutic Indications (including gastroparesis, GERD, IBD, IBS and Celiac Disease)
“We are pleased to offer this educational series and to deliver programs that provide valuable information to pharmaceutical and biotech researchers,” said Scott Dixon, Vice President, Marketing, ERT. “The Endpoints to Insights series offers a convenient means for busy researchers and stakeholders to stay abreast of proven advances and current industry trends which will support their immediate and long-term development goals.”
ERT is a leading provider of high-quality patient safety and efficacy endpoint data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the efficiency of the clinical development process throughout the product life cycle. ERT delivers the most widely deployed solutions in centralized Cardiac Safety, Respiratory, Suicide Risk Assessment, electronic Clinical Outcome Assessments (eCOA) – which includes patient-, clinician-, observer- and performance-reported outcomes – and cloud-based analytics and performance metrics. By efficiently integrating these solutions through a system built upon a scientific and regulatory foundation, ERT collects, analyzes and delivers safety and efficacy data critical to the approval, labeling and reimbursement of pharmaceutical products. ERT is a global organization with headquarters in Philadelphia, PA and offices throughout the U.S., U.K., Switzerland, Japan and Germany. Join ERT on Facebook, LinkedIn, Twitter, and YouTube.